Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in clinical trials to cut the risk of death by more than 40%. The trial results ...

Prostate cancer is still among the most prevalent cancers of men globally, but timely detection is everything. Over recent years, medical professionals have been emphasizing the key role of a simple ...

Focusing prostate cancer testing on men at highest risk of developing the disease is likely to improve the ratio between benefits and the harms of screening, suggests a paper published today in BMJ.

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Those with prostate cancer that returns after surgery or radiation—and ...

Prostate cancer incidence is increasing, especially in advanced stages, reversing previous declines and slowing mortality rate improvements. Racial disparities persist, with Black and Native American ...

The issues affecting you. Revealed. Explained. Discussed. Now on WGAL 8 InFocus. Hello, I'm Susan Shapiro. About 1 in 8 men will be diagnosed with prostate cancer in their lifetime. The American ...

Johnson & Johnson's Erleada drug, combined with hormone therapy, significantly reduces the risk of prostate cancer spread and ...

The World Health Organization tempered optimism about improvements in cancer treatment and said global health care inequities ...

“What hurts the most is knowing this didn’t need to be how things turned out,” Diane Adams said of her husband Terry’s death ...

Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the ...

"Please, please, please go and get checked," Clarkson, who also underwent heart surgery, urged fans ...

A grandfather died of prostate cancer after GPs ignored his symptoms for nine years. Terry Adams first went to his family ...